Importantly, the methyltransferase NSUN2 also showed increased signal intensity in the clinical RB samples, as demonstrated by RNA‐seq (Figure 1C, deposited in GEO database, GSE111168) and immunofluorescence assays (Figure 1D and Figure S1A). This evidence concerns the gene NSUN2 and retinoblastoma.